nodes	percent_of_prediction	percent_of_DWPC	metapath
Diltiazem—CYP3A5—Teniposide—lymphatic system cancer	0.109	0.155	CbGbCtD
Diltiazem—CYP2C19—Teniposide—lymphatic system cancer	0.0879	0.125	CbGbCtD
Diltiazem—CYP2C9—Teniposide—lymphatic system cancer	0.0731	0.104	CbGbCtD
Diltiazem—CYP3A7—Vincristine—lymphatic system cancer	0.0699	0.0995	CbGbCtD
Diltiazem—CYP3A7-CYP3A51P—Vincristine—lymphatic system cancer	0.0699	0.0995	CbGbCtD
Diltiazem—CYP3A5—Vincristine—lymphatic system cancer	0.0525	0.0747	CbGbCtD
Diltiazem—ABCB1—Mitoxantrone—lymphatic system cancer	0.0496	0.0706	CbGbCtD
Diltiazem—CYP3A4—Cytarabine—lymphatic system cancer	0.0432	0.0614	CbGbCtD
Diltiazem—CYP3A4—Teniposide—lymphatic system cancer	0.0425	0.0605	CbGbCtD
Diltiazem—ABCB1—Vincristine—lymphatic system cancer	0.0341	0.0486	CbGbCtD
Diltiazem—CYP3A4—Mitoxantrone—lymphatic system cancer	0.0297	0.0423	CbGbCtD
Diltiazem—ABCB1—Methotrexate—lymphatic system cancer	0.0207	0.0294	CbGbCtD
Diltiazem—CYP3A4—Vincristine—lymphatic system cancer	0.0205	0.0291	CbGbCtD
Diltiazem—Pain—Fludarabine—lymphatic system cancer	0.000596	0.00201	CcSEcCtD
Diltiazem—Constipation—Fludarabine—lymphatic system cancer	0.000596	0.00201	CcSEcCtD
Diltiazem—Bradycardia—Mitoxantrone—lymphatic system cancer	0.000594	0.002	CcSEcCtD
Diltiazem—Vasculitis—Methotrexate—lymphatic system cancer	0.000594	0.002	CcSEcCtD
Diltiazem—Urinary tract disorder—Vincristine—lymphatic system cancer	0.000592	0.00199	CcSEcCtD
Diltiazem—Blood uric acid increased—Methotrexate—lymphatic system cancer	0.00059	0.00198	CcSEcCtD
Diltiazem—Urethral disorder—Vincristine—lymphatic system cancer	0.000588	0.00198	CcSEcCtD
Diltiazem—Eye disorder—Carmustine—lymphatic system cancer	0.000587	0.00197	CcSEcCtD
Diltiazem—Rhinitis—Mitoxantrone—lymphatic system cancer	0.000585	0.00197	CcSEcCtD
Diltiazem—Hypersensitivity—Teniposide—lymphatic system cancer	0.000585	0.00197	CcSEcCtD
Diltiazem—Hepatitis—Mitoxantrone—lymphatic system cancer	0.000584	0.00196	CcSEcCtD
Diltiazem—Flushing—Carmustine—lymphatic system cancer	0.000583	0.00196	CcSEcCtD
Diltiazem—Ill-defined disorder—Bleomycin—lymphatic system cancer	0.000581	0.00196	CcSEcCtD
Diltiazem—Pharyngitis—Mitoxantrone—lymphatic system cancer	0.00058	0.00195	CcSEcCtD
Diltiazem—Vaginal inflammation—Methotrexate—lymphatic system cancer	0.000579	0.00195	CcSEcCtD
Diltiazem—Feeling abnormal—Fludarabine—lymphatic system cancer	0.000575	0.00193	CcSEcCtD
Diltiazem—Asthenia—Teniposide—lymphatic system cancer	0.000569	0.00191	CcSEcCtD
Diltiazem—Cystitis noninfective—Methotrexate—lymphatic system cancer	0.000566	0.0019	CcSEcCtD
Diltiazem—Malaise—Bleomycin—lymphatic system cancer	0.000565	0.0019	CcSEcCtD
Diltiazem—Pruritus—Teniposide—lymphatic system cancer	0.000561	0.00189	CcSEcCtD
Diltiazem—Arrhythmia—Carmustine—lymphatic system cancer	0.000561	0.00189	CcSEcCtD
Diltiazem—Leukopenia—Bleomycin—lymphatic system cancer	0.000561	0.00189	CcSEcCtD
Diltiazem—Cystitis—Methotrexate—lymphatic system cancer	0.000559	0.00188	CcSEcCtD
Diltiazem—Cardiac disorder—Vincristine—lymphatic system cancer	0.000557	0.00187	CcSEcCtD
Diltiazem—Alopecia—Carmustine—lymphatic system cancer	0.000555	0.00187	CcSEcCtD
Diltiazem—Body temperature increased—Fludarabine—lymphatic system cancer	0.000551	0.00185	CcSEcCtD
Diltiazem—Vaginal infection—Methotrexate—lymphatic system cancer	0.000547	0.00184	CcSEcCtD
Diltiazem—Erythema—Carmustine—lymphatic system cancer	0.000547	0.00184	CcSEcCtD
Diltiazem—Malnutrition—Carmustine—lymphatic system cancer	0.000547	0.00184	CcSEcCtD
Diltiazem—Cough—Bleomycin—lymphatic system cancer	0.000547	0.00184	CcSEcCtD
Diltiazem—Angiopathy—Vincristine—lymphatic system cancer	0.000544	0.00183	CcSEcCtD
Diltiazem—Diarrhoea—Teniposide—lymphatic system cancer	0.000543	0.00183	CcSEcCtD
Diltiazem—Mediastinal disorder—Vincristine—lymphatic system cancer	0.00054	0.00182	CcSEcCtD
Diltiazem—Myalgia—Bleomycin—lymphatic system cancer	0.000533	0.00179	CcSEcCtD
Diltiazem—Chest pain—Bleomycin—lymphatic system cancer	0.000533	0.00179	CcSEcCtD
Diltiazem—Alopecia—Vincristine—lymphatic system cancer	0.00053	0.00178	CcSEcCtD
Diltiazem—Discomfort—Bleomycin—lymphatic system cancer	0.000527	0.00177	CcSEcCtD
Diltiazem—Ecchymosis—Methotrexate—lymphatic system cancer	0.000524	0.00176	CcSEcCtD
Diltiazem—Urine output increased—Methotrexate—lymphatic system cancer	0.000524	0.00176	CcSEcCtD
Diltiazem—Bladder pain—Methotrexate—lymphatic system cancer	0.000524	0.00176	CcSEcCtD
Diltiazem—Arrhythmia—Mitoxantrone—lymphatic system cancer	0.000522	0.00175	CcSEcCtD
Diltiazem—Gynaecomastia—Methotrexate—lymphatic system cancer	0.000518	0.00174	CcSEcCtD
Diltiazem—Alopecia—Mitoxantrone—lymphatic system cancer	0.000516	0.00174	CcSEcCtD
Diltiazem—Vision blurred—Carmustine—lymphatic system cancer	0.000515	0.00173	CcSEcCtD
Diltiazem—Hypersensitivity—Fludarabine—lymphatic system cancer	0.000514	0.00173	CcSEcCtD
Diltiazem—Tremor—Carmustine—lymphatic system cancer	0.000512	0.00172	CcSEcCtD
Diltiazem—Oedema—Bleomycin—lymphatic system cancer	0.000511	0.00172	CcSEcCtD
Diltiazem—Erythema—Mitoxantrone—lymphatic system cancer	0.000508	0.00171	CcSEcCtD
Diltiazem—Infection—Bleomycin—lymphatic system cancer	0.000508	0.00171	CcSEcCtD
Diltiazem—Vomiting—Teniposide—lymphatic system cancer	0.000504	0.0017	CcSEcCtD
Diltiazem—Thrombocytopenia—Bleomycin—lymphatic system cancer	0.000501	0.00168	CcSEcCtD
Diltiazem—Asthenia—Fludarabine—lymphatic system cancer	0.0005	0.00168	CcSEcCtD
Diltiazem—Rash—Teniposide—lymphatic system cancer	0.0005	0.00168	CcSEcCtD
Diltiazem—Dermatitis—Teniposide—lymphatic system cancer	0.0005	0.00168	CcSEcCtD
Diltiazem—Dysgeusia—Mitoxantrone—lymphatic system cancer	0.000498	0.00167	CcSEcCtD
Diltiazem—Headache—Teniposide—lymphatic system cancer	0.000497	0.00167	CcSEcCtD
Diltiazem—Pruritus—Fludarabine—lymphatic system cancer	0.000493	0.00166	CcSEcCtD
Diltiazem—Lymphadenopathy—Methotrexate—lymphatic system cancer	0.000493	0.00166	CcSEcCtD
Diltiazem—Leukopenia—Carmustine—lymphatic system cancer	0.000489	0.00165	CcSEcCtD
Diltiazem—Anorexia—Bleomycin—lymphatic system cancer	0.000487	0.00164	CcSEcCtD
Diltiazem—Vision blurred—Mitoxantrone—lymphatic system cancer	0.000479	0.00161	CcSEcCtD
Diltiazem—Photosensitivity—Methotrexate—lymphatic system cancer	0.000479	0.00161	CcSEcCtD
Diltiazem—Polyuria—Methotrexate—lymphatic system cancer	0.000479	0.00161	CcSEcCtD
Diltiazem—Hypotension—Bleomycin—lymphatic system cancer	0.000478	0.00161	CcSEcCtD
Diltiazem—Diarrhoea—Fludarabine—lymphatic system cancer	0.000477	0.0016	CcSEcCtD
Diltiazem—Ill-defined disorder—Mitoxantrone—lymphatic system cancer	0.000472	0.00159	CcSEcCtD
Diltiazem—Nausea—Teniposide—lymphatic system cancer	0.000471	0.00159	CcSEcCtD
Diltiazem—Vertigo—Vincristine—lymphatic system cancer	0.000469	0.00158	CcSEcCtD
Diltiazem—Leukopenia—Vincristine—lymphatic system cancer	0.000467	0.00157	CcSEcCtD
Diltiazem—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.000466	0.00157	CcSEcCtD
Diltiazem—Chest pain—Carmustine—lymphatic system cancer	0.000466	0.00157	CcSEcCtD
Diltiazem—Myalgia—Carmustine—lymphatic system cancer	0.000466	0.00157	CcSEcCtD
Diltiazem—Paraesthesia—Bleomycin—lymphatic system cancer	0.000459	0.00154	CcSEcCtD
Diltiazem—Malaise—Mitoxantrone—lymphatic system cancer	0.000458	0.00154	CcSEcCtD
Diltiazem—Dyspnoea—Bleomycin—lymphatic system cancer	0.000456	0.00153	CcSEcCtD
Diltiazem—Leukopenia—Mitoxantrone—lymphatic system cancer	0.000455	0.00153	CcSEcCtD
Diltiazem—Oedema—Carmustine—lymphatic system cancer	0.000446	0.0015	CcSEcCtD
Diltiazem—Dermatitis exfoliative—Methotrexate—lymphatic system cancer	0.000446	0.0015	CcSEcCtD
Diltiazem—Decreased appetite—Bleomycin—lymphatic system cancer	0.000444	0.00149	CcSEcCtD
Diltiazem—Myalgia—Vincristine—lymphatic system cancer	0.000444	0.00149	CcSEcCtD
Diltiazem—Cough—Mitoxantrone—lymphatic system cancer	0.000444	0.00149	CcSEcCtD
Diltiazem—Infection—Carmustine—lymphatic system cancer	0.000443	0.00149	CcSEcCtD
Diltiazem—Vomiting—Fludarabine—lymphatic system cancer	0.000443	0.00149	CcSEcCtD
Diltiazem—Rash—Fludarabine—lymphatic system cancer	0.00044	0.00148	CcSEcCtD
Diltiazem—Dermatitis—Fludarabine—lymphatic system cancer	0.000439	0.00148	CcSEcCtD
Diltiazem—Pain—Bleomycin—lymphatic system cancer	0.000437	0.00147	CcSEcCtD
Diltiazem—Thrombocytopenia—Carmustine—lymphatic system cancer	0.000437	0.00147	CcSEcCtD
Diltiazem—Headache—Fludarabine—lymphatic system cancer	0.000437	0.00147	CcSEcCtD
Diltiazem—Tachycardia—Carmustine—lymphatic system cancer	0.000436	0.00147	CcSEcCtD
Diltiazem—Chest pain—Mitoxantrone—lymphatic system cancer	0.000433	0.00146	CcSEcCtD
Diltiazem—Myalgia—Mitoxantrone—lymphatic system cancer	0.000433	0.00146	CcSEcCtD
Diltiazem—Arthralgia—Mitoxantrone—lymphatic system cancer	0.000433	0.00146	CcSEcCtD
Diltiazem—Lethargy—Methotrexate—lymphatic system cancer	0.000429	0.00144	CcSEcCtD
Diltiazem—Discomfort—Mitoxantrone—lymphatic system cancer	0.000428	0.00144	CcSEcCtD
Diltiazem—Oedema—Vincristine—lymphatic system cancer	0.000426	0.00143	CcSEcCtD
Diltiazem—Anorexia—Carmustine—lymphatic system cancer	0.000425	0.00143	CcSEcCtD
Diltiazem—Infection—Vincristine—lymphatic system cancer	0.000423	0.00142	CcSEcCtD
Diltiazem—Feeling abnormal—Bleomycin—lymphatic system cancer	0.000421	0.00142	CcSEcCtD
Diltiazem—Osteoarthritis—Methotrexate—lymphatic system cancer	0.000421	0.00141	CcSEcCtD
Diltiazem—Nervous system disorder—Vincristine—lymphatic system cancer	0.000418	0.00141	CcSEcCtD
Diltiazem—Thrombocytopenia—Vincristine—lymphatic system cancer	0.000417	0.0014	CcSEcCtD
Diltiazem—Hypotension—Carmustine—lymphatic system cancer	0.000417	0.0014	CcSEcCtD
Diltiazem—Oedema—Mitoxantrone—lymphatic system cancer	0.000415	0.0014	CcSEcCtD
Diltiazem—Nausea—Fludarabine—lymphatic system cancer	0.000414	0.00139	CcSEcCtD
Diltiazem—Infection—Mitoxantrone—lymphatic system cancer	0.000412	0.00139	CcSEcCtD
Diltiazem—Hyperhidrosis—Vincristine—lymphatic system cancer	0.000412	0.00139	CcSEcCtD
Diltiazem—Shock—Mitoxantrone—lymphatic system cancer	0.000408	0.00137	CcSEcCtD
Diltiazem—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.000407	0.00137	CcSEcCtD
Diltiazem—Thrombocytopenia—Mitoxantrone—lymphatic system cancer	0.000406	0.00137	CcSEcCtD
Diltiazem—Urticaria—Bleomycin—lymphatic system cancer	0.000406	0.00137	CcSEcCtD
Diltiazem—Anorexia—Vincristine—lymphatic system cancer	0.000406	0.00137	CcSEcCtD
Diltiazem—Tachycardia—Mitoxantrone—lymphatic system cancer	0.000405	0.00136	CcSEcCtD
Diltiazem—Body temperature increased—Bleomycin—lymphatic system cancer	0.000404	0.00136	CcSEcCtD
Diltiazem—Insomnia—Carmustine—lymphatic system cancer	0.000404	0.00136	CcSEcCtD
Diltiazem—Hyperhidrosis—Mitoxantrone—lymphatic system cancer	0.000401	0.00135	CcSEcCtD
Diltiazem—Paraesthesia—Carmustine—lymphatic system cancer	0.000401	0.00135	CcSEcCtD
Diltiazem—Mood swings—Methotrexate—lymphatic system cancer	0.000398	0.00134	CcSEcCtD
Diltiazem—Hypotension—Vincristine—lymphatic system cancer	0.000398	0.00134	CcSEcCtD
Diltiazem—Dyspnoea—Carmustine—lymphatic system cancer	0.000398	0.00134	CcSEcCtD
Diltiazem—Somnolence—Carmustine—lymphatic system cancer	0.000397	0.00133	CcSEcCtD
Diltiazem—Anorexia—Mitoxantrone—lymphatic system cancer	0.000395	0.00133	CcSEcCtD
Diltiazem—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	0.000388	0.00131	CcSEcCtD
Diltiazem—Decreased appetite—Carmustine—lymphatic system cancer	0.000388	0.0013	CcSEcCtD
Diltiazem—Hypotension—Mitoxantrone—lymphatic system cancer	0.000388	0.0013	CcSEcCtD
Diltiazem—Insomnia—Vincristine—lymphatic system cancer	0.000385	0.0013	CcSEcCtD
Diltiazem—Gastrointestinal disorder—Carmustine—lymphatic system cancer	0.000385	0.0013	CcSEcCtD
Diltiazem—Paraesthesia—Vincristine—lymphatic system cancer	0.000383	0.00129	CcSEcCtD
Diltiazem—Pain—Carmustine—lymphatic system cancer	0.000382	0.00128	CcSEcCtD
Diltiazem—Constipation—Carmustine—lymphatic system cancer	0.000382	0.00128	CcSEcCtD
Diltiazem—Toxic epidermal necrolysis—Methotrexate—lymphatic system cancer	0.000379	0.00127	CcSEcCtD
Diltiazem—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.000378	0.00127	CcSEcCtD
Diltiazem—Hypersensitivity—Bleomycin—lymphatic system cancer	0.000377	0.00127	CcSEcCtD
Diltiazem—Paraesthesia—Mitoxantrone—lymphatic system cancer	0.000373	0.00125	CcSEcCtD
Diltiazem—Decreased appetite—Vincristine—lymphatic system cancer	0.00037	0.00125	CcSEcCtD
Diltiazem—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.00037	0.00124	CcSEcCtD
Diltiazem—Somnolence—Mitoxantrone—lymphatic system cancer	0.000369	0.00124	CcSEcCtD
Diltiazem—Gastrointestinal disorder—Vincristine—lymphatic system cancer	0.000368	0.00124	CcSEcCtD
Diltiazem—Feeling abnormal—Carmustine—lymphatic system cancer	0.000368	0.00124	CcSEcCtD
Diltiazem—Fatigue—Vincristine—lymphatic system cancer	0.000367	0.00124	CcSEcCtD
Diltiazem—Asthenia—Bleomycin—lymphatic system cancer	0.000367	0.00123	CcSEcCtD
Diltiazem—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.000365	0.00123	CcSEcCtD
Diltiazem—Constipation—Vincristine—lymphatic system cancer	0.000364	0.00123	CcSEcCtD
Diltiazem—Pain—Vincristine—lymphatic system cancer	0.000364	0.00123	CcSEcCtD
Diltiazem—Pruritus—Bleomycin—lymphatic system cancer	0.000362	0.00122	CcSEcCtD
Diltiazem—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.000361	0.00121	CcSEcCtD
Diltiazem—Fatigue—Mitoxantrone—lymphatic system cancer	0.000358	0.0012	CcSEcCtD
Diltiazem—Constipation—Mitoxantrone—lymphatic system cancer	0.000355	0.00119	CcSEcCtD
Diltiazem—Pain—Mitoxantrone—lymphatic system cancer	0.000355	0.00119	CcSEcCtD
Diltiazem—Body temperature increased—Carmustine—lymphatic system cancer	0.000353	0.00119	CcSEcCtD
Diltiazem—Abdominal pain—Carmustine—lymphatic system cancer	0.000353	0.00119	CcSEcCtD
Diltiazem—Abdominal discomfort—Methotrexate—lymphatic system cancer	0.000348	0.00117	CcSEcCtD
Diltiazem—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.000342	0.00115	CcSEcCtD
Diltiazem—Abdominal pain—Vincristine—lymphatic system cancer	0.000337	0.00113	CcSEcCtD
Diltiazem—Body temperature increased—Vincristine—lymphatic system cancer	0.000337	0.00113	CcSEcCtD
Diltiazem—Erectile dysfunction—Methotrexate—lymphatic system cancer	0.000335	0.00113	CcSEcCtD
Diltiazem—Photosensitivity reaction—Methotrexate—lymphatic system cancer	0.000332	0.00112	CcSEcCtD
Diltiazem—Urticaria—Mitoxantrone—lymphatic system cancer	0.00033	0.00111	CcSEcCtD
Diltiazem—Hypersensitivity—Carmustine—lymphatic system cancer	0.000329	0.00111	CcSEcCtD
Diltiazem—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.000328	0.0011	CcSEcCtD
Diltiazem—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.000328	0.0011	CcSEcCtD
Diltiazem—Vomiting—Bleomycin—lymphatic system cancer	0.000325	0.00109	CcSEcCtD
Diltiazem—Rash—Bleomycin—lymphatic system cancer	0.000322	0.00108	CcSEcCtD
Diltiazem—Dermatitis—Bleomycin—lymphatic system cancer	0.000322	0.00108	CcSEcCtD
Diltiazem—Stevens-Johnson syndrome—Methotrexate—lymphatic system cancer	0.000321	0.00108	CcSEcCtD
Diltiazem—Asthenia—Carmustine—lymphatic system cancer	0.00032	0.00108	CcSEcCtD
Diltiazem—Renal failure—Methotrexate—lymphatic system cancer	0.000319	0.00107	CcSEcCtD
Diltiazem—Conjunctivitis—Methotrexate—lymphatic system cancer	0.000315	0.00106	CcSEcCtD
Diltiazem—Hypersensitivity—Vincristine—lymphatic system cancer	0.000314	0.00106	CcSEcCtD
Diltiazem—Sweating—Methotrexate—lymphatic system cancer	0.000311	0.00105	CcSEcCtD
Diltiazem—Epistaxis—Methotrexate—lymphatic system cancer	0.000306	0.00103	CcSEcCtD
Diltiazem—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.000306	0.00103	CcSEcCtD
Diltiazem—Asthenia—Vincristine—lymphatic system cancer	0.000306	0.00103	CcSEcCtD
Diltiazem—Diarrhoea—Carmustine—lymphatic system cancer	0.000305	0.00103	CcSEcCtD
Diltiazem—Nausea—Bleomycin—lymphatic system cancer	0.000304	0.00102	CcSEcCtD
Diltiazem—Agranulocytosis—Methotrexate—lymphatic system cancer	0.000302	0.00102	CcSEcCtD
Diltiazem—Asthenia—Mitoxantrone—lymphatic system cancer	0.000298	0.001	CcSEcCtD
Diltiazem—Dizziness—Carmustine—lymphatic system cancer	0.000295	0.000993	CcSEcCtD
Diltiazem—Diarrhoea—Vincristine—lymphatic system cancer	0.000291	0.00098	CcSEcCtD
Diltiazem—Hepatitis—Methotrexate—lymphatic system cancer	0.000291	0.000979	CcSEcCtD
Diltiazem—Pharyngitis—Methotrexate—lymphatic system cancer	0.000289	0.000971	CcSEcCtD
Diltiazem—Urinary tract disorder—Methotrexate—lymphatic system cancer	0.000287	0.000966	CcSEcCtD
Diltiazem—Urethral disorder—Methotrexate—lymphatic system cancer	0.000285	0.000959	CcSEcCtD
Diltiazem—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.000284	0.000955	CcSEcCtD
Diltiazem—Vomiting—Carmustine—lymphatic system cancer	0.000284	0.000954	CcSEcCtD
Diltiazem—Dizziness—Vincristine—lymphatic system cancer	0.000282	0.000948	CcSEcCtD
Diltiazem—Rash—Carmustine—lymphatic system cancer	0.000281	0.000946	CcSEcCtD
Diltiazem—Dermatitis—Carmustine—lymphatic system cancer	0.000281	0.000946	CcSEcCtD
Diltiazem—Visual impairment—Methotrexate—lymphatic system cancer	0.00028	0.000943	CcSEcCtD
Diltiazem—Headache—Carmustine—lymphatic system cancer	0.00028	0.00094	CcSEcCtD
Diltiazem—Erythema multiforme—Methotrexate—lymphatic system cancer	0.000275	0.000925	CcSEcCtD
Diltiazem—Eye disorder—Methotrexate—lymphatic system cancer	0.000272	0.000915	CcSEcCtD
Diltiazem—Tinnitus—Methotrexate—lymphatic system cancer	0.000271	0.000912	CcSEcCtD
Diltiazem—Vomiting—Vincristine—lymphatic system cancer	0.000271	0.000911	CcSEcCtD
Diltiazem—Cardiac disorder—Methotrexate—lymphatic system cancer	0.00027	0.000908	CcSEcCtD
Diltiazem—Rash—Vincristine—lymphatic system cancer	0.000269	0.000903	CcSEcCtD
Diltiazem—Dermatitis—Vincristine—lymphatic system cancer	0.000268	0.000903	CcSEcCtD
Diltiazem—Headache—Vincristine—lymphatic system cancer	0.000267	0.000898	CcSEcCtD
Diltiazem—Nausea—Carmustine—lymphatic system cancer	0.000265	0.000892	CcSEcCtD
Diltiazem—Angiopathy—Methotrexate—lymphatic system cancer	0.000264	0.000888	CcSEcCtD
Diltiazem—Vomiting—Mitoxantrone—lymphatic system cancer	0.000264	0.000887	CcSEcCtD
Diltiazem—Mediastinal disorder—Methotrexate—lymphatic system cancer	0.000262	0.000882	CcSEcCtD
Diltiazem—Rash—Mitoxantrone—lymphatic system cancer	0.000262	0.00088	CcSEcCtD
Diltiazem—Dermatitis—Mitoxantrone—lymphatic system cancer	0.000261	0.000879	CcSEcCtD
Diltiazem—Headache—Mitoxantrone—lymphatic system cancer	0.00026	0.000874	CcSEcCtD
Diltiazem—Alopecia—Methotrexate—lymphatic system cancer	0.000257	0.000865	CcSEcCtD
Diltiazem—Malnutrition—Methotrexate—lymphatic system cancer	0.000253	0.000852	CcSEcCtD
Diltiazem—Erythema—Methotrexate—lymphatic system cancer	0.000253	0.000852	CcSEcCtD
Diltiazem—Nausea—Vincristine—lymphatic system cancer	0.000253	0.000851	CcSEcCtD
Diltiazem—Dysgeusia—Methotrexate—lymphatic system cancer	0.000248	0.000834	CcSEcCtD
Diltiazem—Nausea—Mitoxantrone—lymphatic system cancer	0.000246	0.000829	CcSEcCtD
Diltiazem—Vision blurred—Methotrexate—lymphatic system cancer	0.000239	0.000803	CcSEcCtD
Diltiazem—Ill-defined disorder—Methotrexate—lymphatic system cancer	0.000235	0.00079	CcSEcCtD
Diltiazem—Malaise—Methotrexate—lymphatic system cancer	0.000228	0.000768	CcSEcCtD
Diltiazem—Vertigo—Methotrexate—lymphatic system cancer	0.000228	0.000765	CcSEcCtD
Diltiazem—Leukopenia—Methotrexate—lymphatic system cancer	0.000227	0.000763	CcSEcCtD
Diltiazem—Cough—Methotrexate—lymphatic system cancer	0.000221	0.000743	CcSEcCtD
Diltiazem—Arthralgia—Methotrexate—lymphatic system cancer	0.000216	0.000725	CcSEcCtD
Diltiazem—Chest pain—Methotrexate—lymphatic system cancer	0.000216	0.000725	CcSEcCtD
Diltiazem—Myalgia—Methotrexate—lymphatic system cancer	0.000216	0.000725	CcSEcCtD
Diltiazem—Discomfort—Methotrexate—lymphatic system cancer	0.000213	0.000717	CcSEcCtD
Diltiazem—Infection—Methotrexate—lymphatic system cancer	0.000205	0.000691	CcSEcCtD
Diltiazem—Nervous system disorder—Methotrexate—lymphatic system cancer	0.000203	0.000682	CcSEcCtD
Diltiazem—Thrombocytopenia—Methotrexate—lymphatic system cancer	0.000202	0.000681	CcSEcCtD
Diltiazem—Hyperhidrosis—Methotrexate—lymphatic system cancer	0.0002	0.000672	CcSEcCtD
Diltiazem—Anorexia—Methotrexate—lymphatic system cancer	0.000197	0.000663	CcSEcCtD
Diltiazem—Hypotension—Methotrexate—lymphatic system cancer	0.000193	0.00065	CcSEcCtD
Diltiazem—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	0.000188	0.000633	CcSEcCtD
Diltiazem—Insomnia—Methotrexate—lymphatic system cancer	0.000187	0.000629	CcSEcCtD
Diltiazem—Paraesthesia—Methotrexate—lymphatic system cancer	0.000186	0.000624	CcSEcCtD
Diltiazem—Dyspnoea—Methotrexate—lymphatic system cancer	0.000184	0.00062	CcSEcCtD
Diltiazem—Somnolence—Methotrexate—lymphatic system cancer	0.000184	0.000618	CcSEcCtD
Diltiazem—Dyspepsia—Methotrexate—lymphatic system cancer	0.000182	0.000612	CcSEcCtD
Diltiazem—Decreased appetite—Methotrexate—lymphatic system cancer	0.00018	0.000604	CcSEcCtD
Diltiazem—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	0.000178	0.0006	CcSEcCtD
Diltiazem—Fatigue—Methotrexate—lymphatic system cancer	0.000178	0.000599	CcSEcCtD
Diltiazem—Pain—Methotrexate—lymphatic system cancer	0.000177	0.000595	CcSEcCtD
Diltiazem—Feeling abnormal—Methotrexate—lymphatic system cancer	0.00017	0.000573	CcSEcCtD
Diltiazem—Urticaria—Methotrexate—lymphatic system cancer	0.000164	0.000552	CcSEcCtD
Diltiazem—Abdominal pain—Methotrexate—lymphatic system cancer	0.000163	0.00055	CcSEcCtD
Diltiazem—Body temperature increased—Methotrexate—lymphatic system cancer	0.000163	0.00055	CcSEcCtD
Diltiazem—Hypersensitivity—Methotrexate—lymphatic system cancer	0.000152	0.000512	CcSEcCtD
Diltiazem—Asthenia—Methotrexate—lymphatic system cancer	0.000148	0.000499	CcSEcCtD
Diltiazem—Pruritus—Methotrexate—lymphatic system cancer	0.000146	0.000492	CcSEcCtD
Diltiazem—Diarrhoea—Methotrexate—lymphatic system cancer	0.000141	0.000476	CcSEcCtD
Diltiazem—Dizziness—Methotrexate—lymphatic system cancer	0.000137	0.00046	CcSEcCtD
Diltiazem—Vomiting—Methotrexate—lymphatic system cancer	0.000131	0.000442	CcSEcCtD
Diltiazem—Rash—Methotrexate—lymphatic system cancer	0.00013	0.000438	CcSEcCtD
Diltiazem—Dermatitis—Methotrexate—lymphatic system cancer	0.00013	0.000438	CcSEcCtD
Diltiazem—Headache—Methotrexate—lymphatic system cancer	0.000129	0.000436	CcSEcCtD
Diltiazem—Nausea—Methotrexate—lymphatic system cancer	0.000123	0.000413	CcSEcCtD
